Search

everythinglearnresearchcommunity

for

Search:↓

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

New treatment effectively reverses hair thinning in most patients with mild side effects.

AMT may cause hair loss and changing dWAT activity could help treat it.

Botulinum toxin is not effective for treating male hair loss.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

A new treatment for hair loss shows promise with fewer side effects.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Adding a cosmetic gel with caffeine, taurine, and growth factors to standard hair loss treatments could improve results.

Targeting ATM could help manage heart cell enlargement due to pressure overload.

Gene variations may increase oxidative stress in male pattern baldness.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

The treatment showed promising results in improving advanced-stage hair loss.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Transglutaminase-3 is often reduced in esophageal cancer.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.